Hikma Manages To Stay Flat In 2022 Despite Generics Pressures
Annual Results See Injectables And Brands Success Offsetting Struggling Generics Unit
• By David Wallace
Growing returns from injectables and brands are helping to balance downwards pressures on Hikma’s generics business • Source: Shutterstock 
